NASDAQ:CTXR

Citius Pharmaceuticals Earning Date

USA |NASDAQ |USD

CTXR Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Dec 14, 2021 Sep 2021 $-0.03 $-0.05 $-0.07
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Dec 14, 2021 Sep 2021 $0.00 $0.00 $0.00

Citius Pharmaceuticals's next earnings date is Tuesday, Dec 14, 2021 for the fiscal quarter ending Sep 2021.

CTXR Earnings Date & History Chart

CTXR Earnings & Revenue Forecast

CTXR Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $0.07 $0.07 $0.07
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 1 $-0.15 $-0.15 $-0.15

CTXR Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $0.07 $0.07 $0.07
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Sep 2022 0 / 0 $-0.15 $0.31 $0.31

CTXR Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 1 $19.15M $19.15M $19.15M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 1 $0.00 $0.00 $0.00

CTXR Earnings Date & Revenue History

CTXR Earnings History

|
Show More
Show More

CTXR Revenue History

|
Show More
Show More

Citius Pharmaceuticals Next Earnings Date & Report

CTXR Next Earnings Date & Report Preview: Sep 2021 (FQ)

CTXR's next earnings date is Tuesday, Dec 14, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 1 analysts, the average EPS estimation for Citius Pharmaceuticals's next quarterly earnings is $-0.03, with a low EPS estimation of $-0.03, and a high estimation of $-0.03.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.03, the last 2 month trend is $-0.07, and the 3 month trend is $-0.07.

Based on 1 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Citius Pharmaceuticals Previous Earnings Dates & Reports

CTXR Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Citius Pharmaceuticals's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

CTXR's earnings per share (EPS) was $-0.05, missing the consensus analysts forecast of $-0.04 by -25.00%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 25.00%, and higher than the same period a year before (Jun 2020) by -54.55%.

Revenues were $0.00.

The company reported a net income of $-5.82M.

Free cash flow for the quarter was $-4.83M , compared to $-4.27M last quarter and $-3.99M a year before.

CTXR ended the quarter with $1.06M in total debt, a decrease of -16.69% compared to the previous quarter, and an increase of 214.59% compared to the same quarter a year before.

CTXR Previous Earnings Date & Report Recap: Sep 2020 (FY)

Citius Pharmaceuticals's previous annual earnings date was Dec 16, 2020 for its fiscal year ended Sep 30, 2020.

CTXR's earnings per share (EPS) was $-0.46, beating the consensus analysts forecast of $-0.46 by 0.00% , and higher than the previous year's EPS (Sep 2019) by -41.03%.

Revenues were $0.00.

The company reported a net income of $-17.55M.

Citius Pharmaceuticals reported a free cash flow of $-16.93M for its fiscal year, compared to $-12.44M a year ago.

The company ended the fiscal year with $496.55K in total debt, an increase of 187.07% compared to the previous year.